Take the steps now
to secure your future
LYNCHNOW® is a cost-effective, comprehensive screening that rapidly detects mutations that causes Lynch syndrome.
Lynch syndrome is an inherited condition that increases your risk of developing cancer.

Lynch syndrome, often called Hereditary Nonpolyposis Colorectal Cancer (HNPCC), affects both men and women. It increases the risk of several cancers, particularly cancers of the colon (large intestine) and rectum.

Lynch syndrome is an inherited condition that increases your risk of developing colon cancer and other cancers associated with this syndrome. Lynch syndrome is hereditary, which means it is caused by genetic changes that can be passed from parents to their children.
Did you know?
About 1 in every 500 women in the United States has a mutation in either her BRCA1 or BRCA2 gene.

However, for some ethnic groups, such as the Ashkenazi Jewish population, the risk of carrying a BRCA mutation increases to 1 in 40
LYNCHNOW® delivers timely and cost-efficient results.
The protocol, which is largely accepted throughout the medical field, consists of first screening for DNA mismatch repair (MMR) proteins MLH1, MSH2, MSH6, and PMS2 by way of immunohistochemistry.

This process gives results in 3-5 days and allows the clinician to make a rapid decision on the next step.
Benefits of LYNCHNOW
Predicting prognosis for Lynch syndrome
Predicting therapeutic responses for Lynch syndrome
Predicting risk for Lynch syndrome
How LYNCHNOW® testing works
Patient Consult
Physician & patient discuss the benefits of LYNCHNOW®.
Sample Collection
The test can be performed using blood or saliva
Sample Processing
Your Sample is Analyzed in our Lab
Your LYNCHNOW® report will be available within 10-14 days.
We're here to guide you through the process.
Part of LYNCHNOW® includes genetic counseling to walk you through our process and test results, along with any lifestyle or treatment alternatives depending on your results.